Venture Update: Venous Stent appoints Darren Spencer as CEO and participates at LSI Europe

We are delighted to announce that Darren Spencer has been appointed Chief Executive Officer of Venous Stent B.V., one of NLC’s ventures developing next-generation solutions in vascular intervention.

This week, Darren will represent Venous Stent at LSI Europe in London, one of the leading global forums for medical technology innovation. The conference brings together entrepreneurs, investors, and clinical leaders to highlight emerging solutions that are shaping the future of healthcare. Visitors to LSI Europe will have the opportunity to meet Darren and learn more about Venous Stent’s innovative approach to advancing venous stenting.

Venous Stent B.V. is developing a novel iliac venous stent platform, specifically designed to overcome the anatomical challenges that have limited existing devices. By providing improved treatment options for patients suffering from venous outflow obstruction and related conditions, the company is addressing a significant unmet medical need.

With Darren’s appointment as CEO, Venous Stent is well positioned to accelerate its development pathway. The company is preparing for its first-in-human study while actively building strategic collaborations to support clinical adoption and regulatory approval.

At NLC, we are proud to support the Venous Stent team in their mission to improve patient outcomes through innovation, and we look forward to following their journey as they continue to grow and make an impact.

‍